In agreement with our PCa data, FOXA1 OE resulted in a significant decrease while FOXA1 KO manifested in a significant increase of NR3C1 expression in bladder tumor organoids (Figure 6E). This evidence concerns the gene FOXA1 and urinary bladder neoplasm.